Drinking-Water 4,4′-Methylenedianiline Establishes a Longitudinally Tractable Mouse Model of Cholestatic Liver Injury
4 affiliations
- 1the University of Tokyo Graduate School of Pharmaceutical Sciences, , Bunkyo-ku, Tokyo, 113-0033,
- 2Graduate School of Pharmaceutical Sciences, the University of Tokyo, Bunkyo-ku, Tokyo, 3-0033, Japan
- 3Graduate School of Pharmaceutical Sciences, the University of Tokyo, Bunkyo-ku, Tokyo, 113-0033, Japan
- 4Laboratory for Drug Discovery and Development, SHIONOGI & Co.,Ltd . Toyonaka, Osaka, 561-0825,
Abstract
Longitudinal studies of liver injury require models that can be maintained with simple administration, low procedure-related stress, and acceptable survival. Drinking-water thioacetamide (TAA-DW) is useful for this purpose, but it mainly produces centrilobular hepatocellular injury. Few drinking-water models are available for cholestatic liver injury. Here, we tested whether 4,4'-methylenedianiline (MDA), a known bile-duct-damaging hepatotoxicant, can be used to build a practical drinking-water model of cholestatic liver injury in mice. Male C57BL/6JJcl mice received MDA in drinking water for up to 28 days. A route- and administration-schedule-matched TAA-DW model was used as a reference. Drinking-water MDA (MDA-DW) caused sustained ALT elevation without observed mortality under the tested regimen. Compared with TAA-DW, MDA-DW produced stronger cholestatic biochemical features, including increased ALP, TBIL, and TCHO. Histology showed bile duct hyperplasia with degeneration, periportal/peribiliary fibrosis, and scattered focal hepatocellular necrosis. Whole-slide image analysis supported the distinct lesion distribution between MDA-DW and TAA-DW. Early time-resolved multimodal profiling showed model-specific responses: MDA-DW showed ALT elevation around Days 2-3, increased CD8-positive T cells on Day 8, and enrichment of fibrinolysis-related gene sets, whereas TAA-DW showed a sharp early injury peak and transient eosinophil increase. Impact Statement: This study expands the range of drinking-water liver injury models by providing a low-mortality MDA-DW model with cholestatic liver injury. The model offers a simple platform for time-resolved studies of liver injury progression, tissue remodeling, and model-specific inflammatory responses.
Related
- Baseline network connectivity is longitudinally associated with internalizing symptoms through conduct problems in adolescents
- Syphilitic Hepatitis Presenting As Cholestatic Liver Injury: A Case Report
- Suspected fibrosing cholestatic hepatitis in an immunocompetent child with hepatitis C: Case report
- Severe Hypercalcemia and Acute Kidney Injury in a Patient with Probable IgG4-Related Disease and Cholestatic Liver Injury: A Case Report
- Longitudinally Extensive Hemorrhagic Myelitis in a Young Adult With Newly Diagnosed Duodenal Adenocarcinoma.
BibTeX
@article{iwasaka2026drinkingwater,
title = {{Drinking-Water 4,4′-Methylenedianiline Establishes a Longitudinally Tractable Mouse Model of Cholestatic Liver Injury}},
author = {Takumi Iwasaka and Katsuhisa Morita and Iori Azuma and Tomoka Nakagawa and Eri Nakashima and Tomomi Kamei and Yuki Kato and Hiroyuki Kusuhara and Tadahaya Mizuno},
journal = {Toxicological Sciences},
year = {2026},
month = oct,
doi = {10.1093/toxsci/kfag142},
url = {https://doi.org/10.1093/toxsci/kfag142},
note = {CC BY},
}
RIS
TY - JOUR
TI - Drinking-Water 4,4′-Methylenedianiline Establishes a Longitudinally Tractable Mouse Model of Cholestatic Liver Injury
AU - Takumi Iwasaka
AU - Katsuhisa Morita
AU - Iori Azuma
AU - Tomoka Nakagawa
AU - Eri Nakashima
AU - Tomomi Kamei
AU - Yuki Kato
AU - Hiroyuki Kusuhara
AU - Tadahaya Mizuno
PY - 2026
DA - 2026/10/31
JO - Toxicological Sciences
DO - 10.1093/toxsci/kfag142
UR - https://doi.org/10.1093/toxsci/kfag142
AB - Longitudinal studies of liver injury require models that can be maintained with simple administration, low procedure-related stress, and acceptable survival. Drinking-water thioacetamide (TAA-DW) is useful for this purpose, but it mainly produces centrilobular hepatocellular injury. Few drinking-water models are available for cholestatic liver injury. Here, we tested whether 4,4'-methylenedianiline (MDA), a known bile-duct-damaging hepatotoxicant, can be used to build a practical drinking-water model of cholestatic liver injury in mice. Male C57BL/6JJcl mice received MDA in drinking water for up to 28 days. A route- and administration-schedule-matched TAA-DW model was used as a reference. Drinking-water MDA (MDA-DW) caused sustained ALT elevation without observed mortality under the tested regimen. Compared with TAA-DW, MDA-DW produced stronger cholestatic biochemical features, including increased ALP, TBIL, and TCHO. Histology showed bile duct hyperplasia with degeneration, periportal/peribiliary fibrosis, and scattered focal hepatocellular necrosis. Whole-slide image analysis supported the distinct lesion distribution between MDA-DW and TAA-DW. Early time-resolved multimodal profiling showed model-specific responses: MDA-DW showed ALT elevation around Days 2-3, increased CD8-positive T cells on Day 8, and enrichment of fibrinolysis-related gene sets, whereas TAA-DW showed a sharp early injury peak and transient eosinophil increase. Impact Statement: This study expands the range of drinking-water liver injury models by providing a low-mortality MDA-DW model with cholestatic liver injury. The model offers a simple platform for time-resolved studies of liver injury progression, tissue remodeling, and model-specific inflammatory responses.
SN - 1096-0929
SN - 1096-6080
ER -